Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus

Inclusion Criteria: * Provision of informed consent prior to any study specific procedures * Men or women age ≥20 years old (Either gender needs to be 40% or higher of total number of treated subjects)diagnosed with type 2 DM ; ≥6.5% and ≤10% at 1 week before randomization Exclusion Criteria: * Type 1 diabetes mellitus * FPG \>240 mg/dL before randomization * Subjects who have history of unstable or rapidly progressing renal disease * Subjects who have severe hepatic insufficiency and/or significant abnormal liver function * Significant cardiovascular history